 

<http://www.abbs.info> <http://www.abbs.info/archive.htm>
<http://www.abbs.info/search.htm> <http://www.abbs.info/submit.htm>
<http://www.abbs.info/contact.htm> <http://www.abbs.info/cdefault.htm>

*Journal Home*
  	*Aims and Scope* <http://www.abbs.info/aimscope.htm>
  	*Editorial Board* <http://www.abbs.info/board.htm>
  	*Editorial Office* <http://www.abbs.info/office.htm>
  	*Editorial Policies* <http://www.abbs.info/policies.htm>
  	*News* <http://www.abbs.info/news.htm>

*Authors*
  	*Guide for Authors* <http://www.abbs.info/instrauthor.htm>
	*Submit a Manuscript* <http://www.abbs.info/submit.htm>
  	*Copyright License Form * <http://www.abbs.info/instr/Copyright.pdf>

*Reviewers*
  	*Guide for Reviewers* <http://www.abbs.info/instrreview.htm>
  	*Review a Manuscript* <http://www.abbs.info/review.htm>

*Contact*
  	*Customer Services* <http://www.abbs.info/customer.htm>
*FAQ* <http://www.abbs.info/faq.htm>
  	*Feedback* <http://www.abbs.info/feedback.htm>

*Useful Links <http://www.abbs.info/links.htm>*
 
*Supported by*
  	IBCB, SIBS, CAS <http://www.sibcb.ac.cn/>
*Cooperated with*
  	*Blackwell Publishing* <http://www.blackwellpublishing.com/>
<http://www.blackwellpublishing.com/>
<http://www.blackwell-synergy.com/loi/abbs>

	  	*Guide for Authors* 	
------------------------------------------------------------------------
January 2006

Acta Biochimica et Biophysica Sinica is a scientific journal publishing
monthly research papers, rapid communications and reviews in
biochemistry, molecular biology and biophysics. Research papers and
rapid communications should report original work not published or
considered for publication elsewhere. Reviews should provide a concise
introduction to the subject matter to inform the readers of the latest
developments in a certain area.

*Editorial review and acceptance*

The acceptance criteria for a manuscript are the quality and originality
of the research and its significance to our readership. Except where
otherwise stated, manuscripts are single-blind peer reviewed by at least
two anonymous reviewers and the editor. Final acceptance or rejection
rests with the Editorial Board, who reserves the right to refuse any
material for publication.

*Submission of manuscripts*

Manuscripts should be written in English and submitted online
through our Manuscript Central System
<http://mc.manuscriptcentral.com/abbs>. A registration fee of 150 RMB
payable to Acta Biochimica et Biophysica Sinica is required in the
initial submission (authors outside China are waived of this fee). 

Initial submission should include a cover letter (filling in the cover
letter section) stating that: (i) the content has not been published or
submitted for publication elsewhere; (ii) all authors have contributed
significantly and are in agreement with the content of the manuscript.
Authors must declare any financial support or relationships that may
pose conflict of interest. If tables or figures have been reproduced
from other sources, a letter from the copyright holder (usually the
Publisher) stating authorization to reproduce the material must be
attached to the covering letter.

Submission of revised manuscript should include: (i) the revised
manuscript with revisions marked, (ii) a letter answering all reviewers¡¯
questions.

Submission of the final manuscript should include: (i) the revised
manuscript with revisions marked. (ii) an agreement on transferring the
copyright to the Institute of Biochemistry and Cell Biology with
corresponding author's signature. Authors can download the form from
http://www.abbs.info/instr/Copyright.pdf.

If you have difficulties in using the online submission system, please
feel free to contact the Editorial Office at the following address:

Editorial Office of Acta Biochimica et Biophysica Sinica

The Institute of Biochemistry and Cell Biology, SIBS, CAS
320 Yueyang Road, Shanghai 200031, China
Tel: 86-21-54920956/54920955/54922862; Fax: 86-21-54921011/54920954
E-mail: abbs@sibs.ac.cn <mailto:abbs@sibs.ac.cn>

*Copyright*

The copyright of papers accepted for publication belong to Acta
Biochimica et Biophysica Sinica. In signing the transfer of copyright it
is assumed that authors have obtained permission to use any copyrighted
or previously published material. All authors must read and agree to the
contents outlined in the Copyright License Form
<http://www.abbs.info/instr/Copyright.pdf>, and must sign the Form or
agree that the corresponding author can sign on their behalf. Articles
cannot be published until a signed Copyright License Form has been
received.

*Style of the manuscript*

Manuscripts should follow the style of the Vancouver agreement detailed
in the International Committee of Medical Journal Editors' revised
"Uniform Requirements for Manuscripts Submitted to Biomedical Journals:
Writing and Editing for Biomedical Publication", as presented at
http://www.ICMJE.org/.
Spelling The Journal uses US spelling and authors should therefore
follow the latest edition of the Merriam-Websters Collegiate Dictionary.
Units All measurements must be given in SI or SI-derived units. Please
go to the Bureau International des Poids et Mesures (BIPM) website at
http://www.bipm.fr for more information about SI units.


*Abbreviations *

Abbreviations should be used sparingly-only where they ease the reader's
task by reducing repetition of long, technical terms. Initially use the
word in full, followed by the abbreviation in parentheses. Thereafter
use the abbreviation only.
Genetic nomenclature Standard genetic nomenclature should be used. For
further information, including relevant websites, authors should refer
to the genetic nomenclature guide in Trends in Genetics (Elsevier
Science, 1998).
Nucleotide sequence data can be submitted in electronic form to any of
the three major collaborative databases: DDBJ, EMBL or GenBank. It is
only necessary to submit to one database as data are exchanged between
DDBJ, EMBL and GenBank on a daily basis. The suggested wording for
referring to accession-number information is: "These sequence data have
been submitted to the DDBJ/EMBL/GenBank databases under accession number
U12345." Addresses are as follows:
DNA Data Bank of Japan (DDBJ) http://www.ddbj.nig.ac.jp
EMBL Nucleotide Sequence Submissions http://www.ebi.ac.uk
<http://www.abbs.info///www.ebi.ac.uk>
GenBank http://www.ncbi.nlm.nih.gov

*Format of manuscript *(illustration
<http://www.abbs.info/instr/format.pdf>; example article
<http://www.abbs.info/instr/formateg.pdf>)

An example of the correct format for submitted papers is available on
our website. Research papers should be arranged in the following order:
(i) title, author(s) and affiliation(s); (ii) running title; (iii)
abstract and keywords; (iv) introduction; (v) materials and ethods; (vi)
results; (vii) discussion; (viii) references; (ix) footnote; (x) figure
legends; (xi) tables; (xii) figures. Rapid communications should be
arranged in the following order: (i) title, author(s) and affiliation
(s); (ii) running title; (iii) abstract and keywords; (iv) introduction;
(v) experimental procedures; (vi) results and discussion; (vii)
references; (viii) footnote; (ix) figure legends; (x) tables; (xi)
figures. The locations of figures and tables in the text should be
indicated. Footnotes to the text are not allowed and any such material
should be incorporated into the text as parenthetical matter.

/Title/ The title should be short and informative, less than 20 words,
and should not include non-standard acronyms or abbreviations.
/Title page/ The title page should contain (i) the title of the paper,
(ii) the full names of the authors and (iii) the addresses of the
institutions at which the work was carried out together with (iv) the
full postal and email address, plus facsimile and telephone numbers, of
the author to whom correspondence about the manuscript should be sent.
The present address of any author, if different from that where the work
was carried out, should be supplied in a footnote.
Running title A running title should be provided and should be less than
60 characters.
/Abstract/ The abstract should describe clearly the aim, major findings
and conclusions of the research. It must not exceed 250 words.
/Key words/ Five or fewer key words should be listed below the abstract.
Keywords should be taken from those recommended by the Index Medicus
Medical Subject Headings (MeSH) browser list at
http://www.nlm.nih.gov/mesh/meshhome.html
/Introduction/ The basic principles of research, background, earlier
related work and the purpose of the present studies should be described
in the introduction.
/Experimental procedures/ Experimental procedures should be brief but
complete enough to be repeated; procedures published previously should
be cited in references.
/Results/ It is recommended that results be presented in figures and
tables along with a suitable description in the text.
/Discussion/ The discussion should be concise (no more than three pages)
and focus on the interpretation of the results.
/References/ The Vancouver system of referencing should be used
(examples are given below). In the text, references should be marked
using superscript Arabic numerals in the order in which they appear.
In the reference list, if a reference has many authors, list only the
first seven authors, followed by "/et al/." Reference to unpublished
data and personal communications should not appear in the list but
should be cited in the text only (e.g. Smith A, 2000, unpublished data).
All citations mentioned in the text, tables or figures must be listed in
the reference list.
Names of journals should be abbreviated according to the style used in
Index Medicus. Authors are responsible for the accuracy of the references.
1 Neufeld EB, Remaley AT, Demosky SJ, Stonik JA, Cooney AM, Comly M,
Dwyer NK et al. Cellular localization and trafficking of the human ABCA1
transporter. J Biol Chem 2001, 276: 27584-7590
2 Hanahan D, Jessee J, Bloom FR. Techniques for transformation of E.
coli. In: Glover DM, Hames BD eds. DNA Cloning: A Practical Approach.
2nd ed. England: Oxford University Press 1998, 122-123
/Footnotes/ A footnote below the key words can include (1) source of
grants, (2) present address of any author(s) if required, and (3)
abbreviations used in the text.
/Tables/ Tables should be self-contained and complement, but not
duplicate, information contained in the text. Tables should be
consecutively numbered in the text in Arabic numerals. Type tables on a
separate sheet with the legend on the top. Legends should be concise but
comprehensive--the table, legend and footnotes must be understandable
without reference to the text. Vertical grid lines should not be used to
separate columns. Each column in a table must have a heading, with units
of measurement in parentheses; all abbreviations must be defined in
footnotes.
/Figures/ Figures should be cited in consecutive order in the text, if
possible. Graphs should be drawn professionally or with a computer
graphics package. Pictures should be supplied electronically or as
sharp, glossy, black and white photographic prints and should not be
mounted onto the manuscript. Individual photographs forming a composite
figure should be of equal contrast. Magnifications should be indicated
using a scale bar on the illustration.
Each figure should be labeled indicating name of author(s), figure
number and orientation. Hard-copy photographs should be labeled on the back.
Figure legends Type figure legends on a separate page. Legends should be
concise but comprehensive--the figure and its legend must be
understandable without reference to the text. Include definitions of any
symbols used and define/explain all abbreviations and units of measurement.

*Proofs*

It is essential that corresponding authors supply an email address to
which proofs can be emailed. Full instructions on how to correct and
return the file will be attached to the email. If the proof is not
returned by the appointed date, it may be signed off on by the Editor or
held over to the next issue.

*Page limits*

Reviews should be less than 6 printed pages. Rapid communications are
limited to 5 printing pages. A surcharge of publication fee may be
required for the over-limit printing pages.

*Offprints*

A maximum of 30 offprints will be provided free of charge upon request
and additional offprints are available at 10 RMB ($ 1) per copy. An
Offprint Order Form will be sent to the corresponding author with the
PDF proof.

*Publication fees*

A publication fee of 200 RMB ($ 30) per printed page is required. No
additional charge is required for black-white figures. A surcharged of
800 RMB($ 100) is required for each color page reproduced in the journal. 
Publication fees should be paid to Acta Biochimica et Biophysica Sinica
by Telegragh Transfer or Money Order.


(1) Telegragh transfer
*/ITEM TITLE:/ *Publication fee paid to Acta Biochimica et Biophysica
Sinica  

¡¡

*/INTERMEDIARY BANK:/* First Union National Bank, New York International
Branch.

*/SWIFT CODE: /*PNBPUS3NNYC  

¡¡

*/RECEIVING BANK:/*/ /Agricultural Bank of China, Shanghai Branch, Xuhui
Sub-Branch

*/SWIFT CODE:/*/ /ABOCCNBJ090.
*/A/C Title:/*/ /Shanghai Institutes for Biological Sciences, Chinese
Academy of Sciences (for Acta Biochimica et Biophysica Sinica)
*/A/C No:/  *033924-00801048006

*/ADDRESS:/ *320 Yueyang Road, Shanghai 200031, China


(2) Money Order
Pay to: Acta Biochimica et Biophysica Sinica
Mailing Address: Building 31B, 319 Yueyang Road, Shanghai 200031, China

Authors unable to pay publication fee may apply at the time of
submission for a waiver. Applications must be endorsed by a senior
institutional official.

------------------------------------------------------------------------
Copyright&#169;2005 Acta Biochimica et Biophysica Sinica

